AQILION AB
PrivateLast Round
VC Round
Apr 2, 2025
Est. Valuation
$9.23M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AQILION AB operates in Healthcare & Life Sciences and is based in Helsingborg. Its latest recorded funding round was a VC Round in April 2025.
AQILION AB is a biotechnology company that develops innovative treatments for diseases caused by chronic inflammation and dysfunctional immune reactions, such as autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AQILION AB Comparables
Compare AQILION AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Knopp Biosciences | 80% | |
| EydisBio, Inc. | 77% | |
| Redoxis AB | 77% |
For institutional investors. Book with your work email.
AQILION AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 2, 2025 | ||||
| VC Round | Sep 7, 2022 | ||||
| Strategic | Dec 3, 2021 |
For institutional investors. Book with your work email.
AQILION AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AB Grenspecialisten | VC Round |
| Fåhraeus Startup and Growth | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 223% MoM, reaching 1.4K.
- Jan 6, 2026
Monthly visitors increased 92% MoM.
For institutional investors. Book with your work email.
AQILION AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AQILION AB's valuation, stock price, and market status.
Is AQILION AB a public or private company?
AQILION AB is a private company.
What is the current stock price of AQILION AB?
AQILION AB is a private company, so its shares have no public market price. Caplight tracks AQILION AB's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AQILION AB worth (valuation)?
AQILION AB's valuation is estimated at $9.2M based on funding round data.
Can I buy AQILION AB stock?
AQILION AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AQILION AB's last funding round?
AQILION AB's most recent funding round was VC Round on April 2, 2025.
Who are the main investors in AQILION AB?
Key investors in AQILION AB include AB Grenspecialisten, Fåhraeus Startup and Growth.
Will AQILION AB IPO soon?
No public IPO plans have been announced for AQILION AB.
How can I track AQILION AB secondary market activity?
Caplight tracks bids, offers, and trades in AQILION AB's shares on secondary markets.